Literature DB >> 22280902

Oncogene addiction.

Jeffrey Settleman1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22280902     DOI： 10.1016/j.cub.2011.11.004

Source DB:  PubMed          Journal:  Curr Biol        ISSN： 0960-9822            Impact factor:   10.834


× No keyword cloud information.
  11 in total

Review 1.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 2.  Epiregulin: roles in normal physiology and cancer.

Authors:  David J Riese; Richard L Cullum
Journal:  Semin Cell Dev Biol       Date:  2014-03-12       Impact factor: 7.727

3.  Quantitative and Sensitive Detection of Cancer Genome Amplifications from Formalin Fixed Paraffin Embedded Tumors with Droplet Digital PCR.

Authors:  Lincoln Nadauld; John F Regan; Laura Miotke; Reet K Pai; Teri A Longacre; Shirley S Kwok; Serge Saxonov; James M Ford; Hanlee P Ji
Journal:  Transl Med (Sunnyvale)       Date:  2012

4.  Adaptive Resistance to Immunotherapy Directed Against p53 Can be Overcome by Global Expression of Tumor-Antigens in Dendritic Cells.

Authors:  Matjaz Humar; Marc Azemar; Martina Maurer; Bernd Groner
Journal:  Front Oncol       Date:  2014-10-06       Impact factor: 6.244

Review 5.  ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.

Authors:  Nico Jacobi; Rita Seeboeck; Elisabeth Hofmann; Andreas Eger
Journal:  Cancers (Basel)       Date:  2017-04-12       Impact factor: 6.639

6.  FQI1: a transcription-methylation switch for cancer.

Authors:  Olga A Guryanova; Jonathan D Licht
Journal:  Oncotarget       Date:  2017-02-21

7.  MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity.

Authors:  Renumathy Dhanasekaran; Virginie Baylot; Phuoc T Tran; Dean W Felsher; Minsoon Kim; Sibu Kuruvilla; David I Bellovin; Nia Adeniji; Anand Rajan Kd; Ian Lai; Meital Gabay; Ling Tong; Maya Krishnan; Jangho Park; Theodore Hu; Mustafa A Barbhuiya; Andrew J Gentles; Kasthuri Kannan
Journal:  Elife       Date:  2020-01-14       Impact factor: 8.140

8.  KRAS drives immune evasion in a genetic model of pancreatic cancer.

Authors:  Irene Ischenko; Stephen D'Amico; Manisha Rao; Jinyu Li; Michael J Hayman; Scott Powers; Oleksi Petrenko; Nancy C Reich
Journal:  Nat Commun       Date:  2021-03-05       Impact factor: 14.919

9.  Machine Learning and Systems Biology Approaches to Characterize Dosage-Based Gene Dependencies in Cancer Cells.

Authors:  Kevin Meng-Lin; Choong Yong Ung; Taylor M Weiskittel; Alex Chen; Cheng Zhang; Cristina Correia; Hu Li
Journal:  J Bioinform Syst Biol       Date:  2021-02-26

10.  Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary Convergence.

Authors:  Katherine R Singleton; Lorin Crawford; Elizabeth Tsui; Haley E Manchester; Ophelia Maertens; Xiaojing Liu; Maria V Liberti; Anniefer N Magpusao; Elizabeth M Stein; Jennifer P Tingley; Dennie T Frederick; Genevieve M Boland; Keith T Flaherty; Shannon J McCall; Clemens Krepler; Katrin Sproesser; Meenhard Herlyn; Drew J Adams; Jason W Locasale; Karen Cichowski; Sayan Mukherjee; Kris C Wood
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.